Domů › Rakovina plic › Connecticut › New Haven
Klinické studie Rakovina plic v New Haven, CT
22 studií pro Rakovina plic hledá účastníky v lokalitách v New Haven a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Probíhá náborFáze 3
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · Vzdálenost 3 mi
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
- a dalších 2
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- Yale Cancer Center, New Haven
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Probíhá náborFáze 3
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · Vzdálenost 3 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Probíhá náborFáze 3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
- Smilow Cancer Hospital-Derby Care Center, Derby · Vzdálenost 8 mi
- a dalších 1
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Probíhá náborFáze 3
- Yale University, Smillow Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Probíhá náborFáze 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- a dalších 1
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Probíhá náborFáze 2
- Research Site, New Haven
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Probíhá náborFáze 1
- Yale Cancer Center, New Haven
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Probíhá náborFáze 1/2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Probíhá náborFáze 1/2
- Yale University School of Medicine - Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- Yale University School of Medicine, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Probíhá náborFáze 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Probíhá náborFáze 1
- Yale Cancer Center, New Haven
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Probíhá náborFáze 1
- Xencor Investigative Site, New Haven
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Probíhá náborFáze 1/2
- Yale University Cancer Center, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · Vzdálenost 5 mi
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
- a dalších 2
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Probíhá náborFáze 1
- Smilow Cancer Hospital (Yale University), New Haven
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
- Smilow Cancer Hospital-Derby Care Center, Derby · Vzdálenost 8 mi
- a dalších 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Probíhá náborFáze 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · Vzdálenost 7 mi
- Smilow Cancer Hospital-Derby Care Center, Derby · Vzdálenost 8 mi
- a dalších 1
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
Probíhá náborVítáni zdraví dobrovolníci
- Yale New Haven Medical Center, New Haven
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Probíhá náborObservační studie
- Yale School of Medicine, New Haven
Studie Rakovina plic v jiných městech
- Houston, TX78 studií
- Boston, MA62 studií
- New York City, NY60 studií
- Los Angeles, CA45 studií
- Washington, DC41 studií
- Arlington, VA41 studií
- Chicago, IL41 studií
- Nashville, TN40 studií
- Baltimore, MD40 studií
- St. Louis, MO39 studií
- Columbus, OH37 studií
- Philadelphia, PA36 studií
Další studie v New Haven
- Nemalobuněčný plicní karcinom41 studií
- Rakovina prsu37 studií
- Rakovina (všechny typy)33 studií
- Metastatický karcinom23 studií
- Squamózní buněčný karcinom hlavy a krku22 studií
- Rakovina vaječníků21 studií
- Kolorektální karcinom20 studií
- Rakovina prostaty20 studií
- Předávkování opioidy18 studií
- Porucha užívání alkoholu (AUD)17 studií
- Akutní myeloidní leukemie17 studií
- Rakovina slinivky břišní16 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.